The U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/20/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to The U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical Program
(NASDAQ: AUPH) Delayed: 16.90 -0.06 (0.35%)
Previous Close $16.96    52 Week High $5.69 
Open $16.93    52 Week Low $1.42 
Day High $17.03    P/E N/A 
Day Low $16.80    EPS $0.00 
Volume 1,198,255